Siegfried Holding AG
A global CDMO developing and manufacturing APIs and finished drug products for pharma.
SFZN | SW
Overview
Corporate Details
- ISIN(s):
- CH0014284498 (+3 more)
- LEI:
- 506700J9QD6IF3937W06
- Country:
- Switzerland
- Address:
- Untere Brühlstrasse 4, 4800 Zofingen
- Sector:
- Manufacturing
Description
Siegfried Holding AG is a global contract development and manufacturing organization (CDMO) serving the pharmaceutical industry. The company's core activities involve the development and manufacturing of active pharmaceutical ingredients (APIs), intermediates, and finished drug products. Its portfolio of finished dosage forms includes tablets, capsules, sterile vials, and ampoules. Siegfried provides an integrated service model, supporting partners from process development through to commercial-scale production. The company is also expanding its capabilities into specialized areas, including ophthalmic drugs and viral vectors for cell and gene therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-17 07:00 |
Siegfried announces Chief Financial Officer transition
|
English | 18.6 KB | ||
| 2025-09-29 06:30 |
DINAMIQS opens cGMP manufacturing facility for viral vectors
|
English | 20.5 KB | ||
| 2025-09-29 02:00 |
DINAMIQS opens cGMP manufacturing facility for viral vectors
|
English | 16.6 KB | ||
| 2025-09-26 06:30 |
Change in the Chairmanship of the Board of Directors
|
English | 18.0 KB | ||
| 2025-09-26 02:00 |
Change in the Chairmanship of the Board of Directors
|
English | 14.1 KB | ||
| 2025-09-11 02:00 |
Siegfried successfully places senior bonds of CHF 300 million
|
English | 12.3 KB | ||
| 2025-07-17 06:30 |
Change in Siegfried's Executive Committee
|
English | 17.8 KB | ||
| 2025-05-23 06:30 |
Siegfried expands production capacity for ophthalmic drugs in El Masnou
|
English | 18.6 KB | ||
| 2025-05-23 02:00 |
Siegfried expands production capacity for ophthalmic drugs in El Masnou
|
English | 13.7 KB | ||
| 2025-04-10 15:30 |
Siegfried shareholders approve all proposals at Annual General Meeting 2025
|
English | 19.4 KB | ||
| 2025-02-18 01:00 |
Siegfried reports continued profitable growth fueled by strong underlying busin…
|
English | 19.1 KB | ||
| 2024-12-24 06:30 |
Siegfried once again confirmed in the Dow Jones Sustainability Index Europe
|
English | 15.8 KB | ||
| 2024-12-23 06:30 |
Siegfried once again confirmed in the Dow Jones Sustainability Index Europe
|
English | 15.8 KB | ||
| 2024-12-23 01:00 |
Siegfried once again confirmed in the Dow Jones Sustainability Index Europe
|
English | 12.1 KB | ||
| 2024-12-07 06:30 |
Changes in Siegfried's senior management team
|
English | 17.7 KB |
Automate Your Workflow. Get a real-time feed of all Siegfried Holding AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Siegfried Holding AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Siegfried Holding AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-10-31 | N/A | Executive member | Sell | None | 1,695,000.00 CHF |
| 2024-10-31 | N/A | Executive member | Sell | None | 1,584,260.00 CHF |
| 2024-08-28 | N/A | Executive member | Sell | None | 1,086,000.00 CHF |
| 2024-08-28 | N/A | Executive member | Sell | None | 380,100.00 CHF |
| 2024-08-28 | N/A | Executive member | Sell | None | 362,724.00 CHF |
| 2024-06-14 | N/A | Non-Executive member | Sell | None | 368,930.00 CHF |
| 2024-03-06 | N/A | Executive member | Sell | None | 4,587,500.00 CHF |
| 2024-03-06 | N/A | Executive member | Sell | None | 1,376,250.00 CHF |
| 2024-03-06 | N/A | Executive member | Sell | None | 917,500.00 CHF |
| 2024-03-06 | N/A | Executive member | Sell | None | 458,750.00 CHF |
Peer Companies
